Skip to main content

Elevance Health, Inc. Q3 FY2026 results

  • ELV · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$429.69−0.05%Close 13 Nov 2026 · Market value $96.13B

Elevance Health, Inc. reported revenue of $51.4 billion, up 1.4% from a year earlier, net income of $1.36 billion and diluted earnings per share of $6.27 against $5.32 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).

From its quarterly report, filed 21 Oct 2026. Compiled and checked by AapWire.

Q3 FY2026 against Q3 FY2025

Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.

Elevance Health, Inc. Q3 FY2026 results against the year-ago quarter
MeasureQ3 FY2026Q3 FY2025Change
Revenue$51.43B$50.71B+1.4%
Operating income$1.27B$1.29B−2.0%
Operating margin2.5%2.6%−0.1 pts
Net income$1.36B$1.19B+14.8%
Diluted EPS$6.27$5.32+17.9%
Operating cash flow$1.27B$1.14B+11.6%
Capital expenditure$267.0M$360.0M−25.8%
Free cash flow$1.00B$775.0M+29.0%

Operating KPIs for the quarter

Elevance Health, Inc. operating KPIs, Q3 FY2026
KPIQ3 FY2026Change on a year
Medical membership (Carelon Services Consumers Served)91.0Mdown 6.8%
Product revenue$6.5Bup 4.8%
Service fees revenue$2.3Bup 6.8%

Earlier quarters

Elevance Health, Inc. results, last eight filed quarters
QuarterPeriod endRevenueChange on a yearDiluted EPS
Q3 FY202630 Sep 2026$51.43B+1.4%$6.27
Q2 FY202630 Jun 2026$50.47B+1.4%$6.71
Q1 FY202631 Mar 2026$50.18B+2.6%$8.00
Q4 FY202531 Dec 2025$49.75B+9.5%$2.47
Q3 FY202530 Sep 2025$50.71B+12.4%$5.32
Q2 FY202530 Jun 2025$49.78B+13.4%$7.72
Q1 FY202531 Mar 2025$48.89B+14.8%$9.61
Q4 FY202431 Dec 2024$45.44B+6.6%$1.81

More on Elevance Health, Inc.: financial statements · revenue · earnings per share

ELV's results, as they are filed.

Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.